Quotes 5-day view Delayed Nyse
02/18/2021
02/19/2021
02/22/2021
02/23/2021
02/24/2021
Date
71.52(c)
70.42(c)
70.48(c)
69.64(c)
70.4(c)
Last
7 334 086
6 530 765
6 054 878
8 150 567
5 826 060
Volume
-1.64% -1.54% +0.09% -1.19% +1.09% Change
Sales 2021
280 B - -
Net income 2021
8 093 M - -
Net Debt 2021
50 382 M - -
P/E ratio 2021
11,4x
Yield 2021
2,86%
Sales 2022
292 B - -
Net income 2022
8 916 M - -
Net Debt 2022
44 224 M - -
P/E ratio 2022
10,2x
Yield 2022
2,93%
Capitalization
92 319 M 92 319 M -
EV / Sales 2021
0,51x
EV / Sales 2022
0,47x
Nbr of Employees
300 000
Free-Float
75,3%
CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows:
- medical insurance plan management services (45.9%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information...
Notations Surperformance© of CVS Health Corporation
Trading Rating : Investor Rating :
All news about CVS HEALTH CORPORATION
News in other languages on CVS HEALTH CORPORATION
Analyst Recommendations on CVS HEALTH CORPORATION
Walgreens maintains full-year profit growth forecast; shares rise
Chart CVS HEALTH CORPORATION
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends CVS HEALTH CORPORATION
Short Term Mid-Term Long Term Trends Bearish Bullish Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
BUY
Number of Analysts
27
Average target price
86,55 $
Last Close Price
70,40 $
Spread / Highest target
44,9%
Spread / Average Target
22,9%
Spread / Lowest Target
2,27%
Please enable JavaScript in your browser's settings to use dynamic charts.
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
